Although not related to the basic defect in CF, this may interfere with efficient phagocytosis and contribute to the CF patient's inability to eradicate chronic lung infection.
Introduction
Circulating human neutrophils (PMN) bear on their surface relatively few C3b receptors (CR1)' and only small amounts of their major cell adherence protein, which also serves as the iC3b receptor (CR3) (1) (2) (3) . When PMN are activated by chemoattractants in vitro, the expression of these two molecules increases rapidly by a mechanism involving translocation of presynthesized receptors from intracellular pools to the cell surface (1) (2) (3) (4) (5) . This is believed to be important in allowing the PMN to adhere to the endothelium and follow chemotactic gradients into the tissues, and also in facilitating phagocytosis of complement-coated microorganisms. Patients whose PMN are deficient in CR3 also have deficient expression of other members of this family of adherence proteins on their lymphocytes and monocytes, but their major clinical problems are due to recurrent infections and other manifestations suggestive ofdecreased penetration of PMN into the tissues (6) . This may occur even though their circulating PMN counts are markedly elevated (6) . Previous studies have shown that PMN in the circulation may have increased expression of CR1 and CR3 after intravascular or extracorporeal exposure to complement activation fragments such as C5a des-Arg (7) (8) (9) . Increased CR3 expression on PMN in experimentally induced sterile exudates has also been documented (10, 1 1). However, no data are presently available on the extent of upregulation of these receptors on neutrophils that have migrated from the circulation into naturally occurring inflammatory exudates.
We report here observations on the expression of CR1 and CR3 on inflammatory PMN obtained from an infected site, the pseudomonas-infected lung in cystic fibrosis (CF), as well as from sterile sites, joints involved in juvenile chronic arthritis. The results indicate that PMN from both types of inflammatory sites are similar, and have upregulated CR3 expression to nearly the same level achieved in vitro with the synthetic chemoattractant, FMLP. In contrast, the level of CR1 expression is much closer to the level on unstimulated resting blood cells. This discrepancy in the level of expression of the two receptors in vivo is markedly different from the proportionality of their expression observed under a wide variety of conditions in vitro. We also found comparable differences in CR1 vs. CR3 expression on PMN obtained from the lungs of a patient with chronic pseudomonas pulmonary infection unrelated to CF. This and other data suggest that the relative deficiency in CR1 expression is not related to the underlying defect in CF. A pattern of receptor expression similar to that observed on inflammatory PMN could be reproduced in vitro by treating FMLP-stimulated isolated peripheral blood cells with a variety ofproteases including pseudomonas and neutrophil elastases and with bronchoalveolar lavage supernatants from CF patients. This decrease in CR1 expression was blocked by preincubating the lavage fluid with PMSF and alantitrypsin, which inhibit serine proteases, suggesting that PMN elastase was responsible. Treatment of isolated PMN with elastase impaired their ability to kill opsonized P. aeruginosa.
Our results thus demonstrate that complement receptor upregulation does occur on PMN in inflammatory exudates, but suggest that the expression of CR1 may in turn be reduced due to cleavage by active proteases present in such exudates. Although not related to the underlying cellular defect in CF, this decrease in CR1 expression seems likely to interfere with efficient complement-mediated phagocytosis. This may contribute to the inability of CF patients to clear the chronic pseudomonas infections that have become the major causes of morbidity and mortality in this disease.
Methods
Patients. The primary study population included seven CF patients with chronic pseudomonas lung infection, one child with chronic pseudomonas pulmonary infection unrelated to CF and four others with juvenile chronic arthritis. The CF patients had mild to severe disease, as defined by the activity and physical examination criteria of the scoring system of Schwachman and Kulczycki (12) . They were selected for this study when, in the opinion oftheir primary physician, bronchoscopy was indicated for diagnostic or therapeutic purposes, or when their condition permitted elective lavage for research purposes. Ten bronchoalveolar lavages were performed on these seven patients. The characteristics of the patients at the time of lavage are given in Table I . All were receiving parenteral antibiotics, generally ceftazadime and tobramycin, as well as vitamins and pancreatic enzyme replacement. Five lavages were performed on patients receiving corticosteroids and two were performed on a patient taking a nonsteroidal antiinflammatory agent (Feldene, Pfizer, Inc., New York). Five additional CF patients, clinically similar to those described in Table I were also lavaged for studies ofthe viability and oxidative metabolism ofthe lavage cells.
Non-CF patients included a 10-mo-old with hypotonia who had a tracheostomy and was chronically infected with P. aeruginosa, and four other patients, ages 5 to 20 yr, with chronic arthritis who underwent diagnostic arthrocentesis and whose joint fluid aspirates were sterile. Heparinized peripheral blood samples of 12-24 ml were obtained from all patients and controls just before their inflammatory fluids were sampled. In addition, control peripheral blood samples were obtained from healthy adult volunteers. Six healthy young adult volunteers also underwent bronchoalveolar lavage. All subjects gave informed consent and all protocols were approved by the Institutional Review Board of University Hospitals of Cleveland. Bronchoalveolar lavage. Subsegmental lavage was performed using a pediatric flexible fiberoptic bronchoscope on awake patients, although some were lightly sedated with small doses of Valium (Roche Products, Inc., Manati, PR). Local anesthesia was achieved with topical lidocaine and/or cocaine. Multiple aliquots of 30-50 ml ofwarmed saline were instilled through the bronchoscope. In most cases the total amount of saline instilled did not exceed 200 ml and the amount recovered was 50-75% of that instilled. Lavage fluid was immediately filtered through surgical gauze to remove mucus plugs and debris. All subsequent steps were performed at 0-40C. Lavage cells were harvested by centrifugation at 200 g for 10 min and washed three times in HBSS without Ca2+ or Mg2' supplemented with 0.1% BSA, 0.01% NaN3 and 10-4 M PMSF (HBSS+); they were then held on ice in this solution. The initial lavage supernatant was centrifuged at 1,000 g for 15 min, then aliquoted and stored at -80°C. Cells from arthrocentesis were handled the same way as lavage cells. Cell counts were performed using a hemocytometer and differential counts were done on Wright's stained cytocentrifuge preparations. Viability of lavage PMN and their capability to produce an oxidative metabolic burst in response to stimulation were assessed by flow cytometry, as described below.
Isolation ofperipheral blood neutrophils. PMN were prepared from heparinized peripheral blood samples as previously described, using Percoll density gradients followed by hypotonic lysis ofcontaminating erythrocytes (3, 13) . Purity and viability ofthese preparations exceeded 95%. PMN were resuspended in HBSS without Ca2+ or Mg2+, which was supplemented with 0.1 % gelatin (HBSS-gel). Cells were stimulated by incubation with the synthetic chemoattractant FMLP at 10-8 M for 1 h at 37°C with intermittent vortexing. In some experiments, lavage or other inflammatory fluid cells were incubated in parallel with the same patient's peripheral blood cells under exactly the same conditions.
Immunofluorescent assessment ofcomplement receptor expression andflow cytometry. After stimulation, aliquots of 106 cells each that had been incubated at 37°C with FMLP or that had been held on ice were washed with HBSS+, and then reacted with monoclonal antibody to the ligand binding site ofCR1 (CD 35, produced by clone 3D9 from Dr. John O'Shea, National Institutes of Health, Bethesda, MD) or to the Mac 1 epitope of CR3 (CD 1 lb, produced by clone M 1/70, obtained from the American Type Culture Collection, Rockville, MD) exactly as previously described (3). Cells were washed and then stained with fluorescein isothiocyanate-conjugated (FITC) F(ab')2 fragments of goat anti-mouse or anti-rat immunoglobulin (Cappel Laboratories, Cochranville, PA) and held on ice until examination in the flow cytometer, generally within 1 h. Equivalent aliquots of cells were also reacted with the directly FITC-conjugated monoclonal antibodies: (3) . For the directly conjugated antibodies, the background determined with directly conjugated isotype matched nonimmune control antibodies was used to set a discriminator and the fraction of cells in a given sample with fluorescence greater than background were expressed as the percent positive.
The level of significance of the differences between the means of fluorescence values or ratios of different samples was determined with Student's t test.
Determination ofviability and oxidative respiratory burst activity of lavage PMN. Since not all cells in the lavage fluid were included in the gates ofthe flow cytometer, which were set to include neutrophils only, we employed fluorescent methods to selectively determine the viability only of those cells falling within the gates and therefore also being analyzed for receptor expression. As the major indicator of viability, membrane integrity was assessed using fluorescein diacetate and propidium iodide (16) . The former is retained and hydrolyzed by cells with intact membranes, yielding green fluorescence; while the latter is excluded from intact cells but binds to nucleic acids of cells with increased membrane permeability, giving red fluorescence. Isolated blood PMN and lavage cells, both at 106/ml, were incubated for 15 min at 37°C in HBSS containing 0.1% gelatin, 5 X l-3 M EDTA and lo-M PMSF, with either 10-5 M fluorescein diacetate or 4 X 10-6 M propidium iodide (both from Sigma Chemical Co., St. Louis, MO). 10,000 cells from each sample were analyzed in the flow cytometer. Discriminators were set based on the symmetric populations of the isolated blood neutrophils, which were > 98% positive for green fluorescence with fluorescein diacetate and < 2% positive for red fluorescence with propidium iodide, as determined by comparison with similar neutrophil preparations that had been permeabilized with 0.01% Triton X-100. Results for lavage neutrophils were expressed as the percentage falling within the discriminators set for intact isolated neutrophils.
To determine the functional capabilities of these cells, we again chose a fluorescence assay so that lavage cells falling within the gates of the flow cytometer could be selectively analyzed. This was done by measuring the oxidation of the nonfluorescent compound, dichlorofluorescin to the highly fluorescent dichlorofluorescein in response to stimulation with phorbol myristate acetate (PMA) as described by Bass et al. (17) . Lavage cells at 106/ml were incubated for 15 min at 37°C with 5 X 1o-0 M dichlorofluorescin-diacetate in HBSS containing 0.1% gelatin, l0-4 M PMSF, and 5 X 10-3 M EDTA. To one of two equivalent aliquots of cells, PMA was added from a stock solution in DMSO to give a final concentration of 100 ng/ml and incubation was continued at 37°C. Fluorescence of 10,000 cells from each sample was recorded just before addition of the phorbol ester and 15-30 min later. Results were expressed as the percent ofcells shifting to higher fluorescence in the presence of PMA as compared to the unstimulated control.
In vitro experiments with isolated normal PMN. To determine the proportionality of CR I and CR3 expression under a variety of conditions, PMN isolated from peripheral blood of normal donors were incubated as described above for FMLP, but the indicated concentrations of the following agents were used to achieve suboptimal levels of stimulation. Leukotriene B4 (LTB4), (Calbiochem-Behring Corp., La Jolla, CA) was used at 10-6, 10-7, and 10-8 M; zymosan-activated serum (ZAS), a source of C5a and C5a des-Arg (18) was used at dilutions of 1:20 to 1: 1,000; purified C5a (19) , was used at 10-', 10-8, and lo-9 M; supernatants of stimulated human peripheral blood monocytes (20) were used at dilutions from 1:8 to 1:256; and recombinant human tumor necrosis factor (Genentech, Inc., San Francisco, CA) was used at 1-24.5 U/ml. After incubation, cells were washed and prepared for flow cytometry as described above.
To determine the effect of proteases on complement receptor expression, PMN were first incubated with FMLP or ZAS for 30 min, then the designated amount of protease or buffer alone was added and incubation was continued for an additional 30 min. Cells were then washed and prepared for immunofluorescence as described above. The proteases used were from the following sources: human leukocyte elastase was purified as described previously (21); pseudomonas elastase was purchased from Nagase Chemical, Osaka, Japan, or purified as described by Obernesser et al. (22); and bovine pancreatic trypsin was purchased from Sigma. To determine the effects of BAL fluid constituents on complement receptor expression by normal PMN, aliquots of BAL supernatants that had been stored at -80°C were added to PMN in the absence or presence of FMLP and incubated at 37°C for I h before being washed and prepared for immunofluorescence staining and flow cytometry as described above. In experiments designed to determine the inhibitor sensitivity of proteases present in the BAL supernatants, aliquots of these fluids were preincubated with various inhibitors or control buffers for 15 min at 37°C, and were then mixed with neutrophil suspensions and FMLP was added to a final concentration of 10-8 M. Incubation was continued at 37°C for 1 h.
The cells were then washed and handled as described above. The compounds tested included: BSA (ICN, Lisle, IL), aI-antitrypsin (Prolastin; Cutter Biologicals, West Haven, CT), 1, 10-phenanthrolene (Aldrich Chemical Co., Milwaukee, WI), EDTA, and phosphoramidon (Sigma). These were all freshly dissolved in HBSS-gel and used at the final concentrations indicated in the text. In addition, the serine protease inhibitor PMSF was purchased from Sigma Chemical Co., and stored as a 1-mM stock solution in dried isopropanol.
In experiments with pyocyanine derivatives or trifluoperazine (Smith Kline & French, Inc., Philadelphia, PA), these compounds were included along with FMLP for the entire 60 min of stimulation. Phenazine was purchased from Sigma Chemical Co. Pyocyanine was prepared by photooxidation of phenazine methosulfate followed by sequential chloroform and aqueous extractions and crystallization from water by the procedure of Knight, as previously described (23, 24) .
PMN bactericidal activity. A clinical isolate of mucoid P. aeruginosa from a CF patient's sputum was subcultured overnight and grown to stationary phase, then washed in PBS and preopsonized by incubation for 45 min at 37°C in 20% pooled fresh human serum that had been depleted of C5 by immunoadsorption using anti-human C5 (Cappel Laboratories). C5 depletion prevents direct bactericidal activity of the serum. These opsonized bacteria (2.0 to 2.5 x 108 colony forming units [cfu] ) were washed in PBS and resuspended in 1.0 ml of a mixture of equal volumes of HBSS-gel and tryptic soy broth (Difco Laboratories, Detroit, MI). Neutrophils (5 X 106/ml) that had been preincubated for 30 min at 37°C in HBSS-gel alone or with 10 gg/ml human neutrophil elastase were washed and resuspended in HBSS-gel, then added to the bacteria suspensions to give a final reaction mixture containing 5 
Results
Complement receptor expression on peripheral blood neutrophils ofcystic fibrosis patients. Before studying inflammatory cells, we first determined whether the peripheral blood neutrophils of cystic fibrosis patients increased complement receptor expression normally in response to stimulation with chemoattractants and whether they were already circulating in an activated state. The preliminary results of nine paired comparisons of isolated peripheral blood neutrophils from CF patients attending our outpatient clinic and healthy controls showed no difference in the baseline state of receptor expression or in the response to FMLP in vitro (26) . To further confirm the premise that the neutrophils in CF could upregulate complement receptor expression normally, the results obtained with the peripheral blood cells of each of the CF patients in this study were compared with the results with a normal control donor run on a consecutive day. As shown in Table II , the baseline levels of CR1 and CR3 expression on the CF patients' neutrophils maintained at 0°C were slightly, but not significantly higher than on the controls' cells. The level of expression of each receptor achieved upon optimal stimulation with 10-8 M FMLP in vitro was also very similar for CF patients and controls. There was no difference in the baseline or stimulated levels of expression of either CR1 or CR3 on cells from the CF patients taking steroids or NSAIDs or those not taking any antiinflammatory agent, as shown below. These results suggested that complement receptor expression during neutrophil activation is not affected by the underlying defect in CF and could therefore be used to assess the state of these cells in situ.
Characterization ofbronchoalveolar lavage (BAL) cells. As shown in Table I , the cells recovered from the CF patients' lavages were predominantly neutrophils. Using volume and right angle light scatter gates on the flow cytometer set to include both resting and FMLP-stimulated blood PMN from each patient, it was possible to selectively analyze granulocytes in these lavage mixtures without further purification and to obtain data on 10,000 cells for each surface antigen considered. Identity of these cells was confirmed for each lavage sample by determining that they were uniformly negative for HLA-DR, (Fig. 1 A) , which is expressed on mononuclear phagocytes and lymphocytes, but not on granulocytes (14); and positive for the marker Leu-1 la (Fig. 1 B) , which is expressed on neutrophils, but not on mononuclear phagocytes (15). This example is for a BAL sample that contained 60% Taken together with the inability of further stimulation with FMLP in vitro to significantly raise the CR1 level on the inflammatory cells, these findings suggested that the decreased CR1 expression was not due to suboptimal stimulation in vivo. We therefore considered it likely that the observed results Effects ofPseudomonas pigments and bacterial and leukocyte proteases on complement receptor expression in vitro. P. aeruginosa is the predominant pathogen responsible for chronic pulmonary infection in CF. We therefore explored the possibility that one of its exoproducts was responsible for the relative deficiency in CR1 expression we observed. Pseudomonas organisms secrete a number of phenazine pigments, including pyocyanine, which have been shown to decrease lymphocyte activation and to inhibit expression of the IL-2 receptor (27, 28). Pyocyanine has also been shown to inhibit O2 production by PMN (26) . These pigments are structurally similar to the phenothiazines, which have previously been shown to inhibit complement receptor upregulation during neutrophil activation (29) . For this reason, we first tested the possibility that phenazines might also inhibit receptor expression on neutrophils and that this might contribute to the decreased CR1 expression we observed on the bronchoalveolar lavage cells. As shown in Fig. 6 , the naturally occurring compound pyocyanine, and phenazine, at concentrations as high as 50 MM, failed to inhibit the FMLP induced upregulation of CR1 and CR3. In contrast, phenazine methosulfate, a synthetic intermediate used for the in vitro preparation of pyocyanine, did cause inhibition at this concentration, while the phenothiazine, trifluoperazine, caused > 50% inhibition at 5 MM, in agreement with our previous findings (29) . The Since it is known that C3b dependent rosetting and immune adherence reactions are sensitive to proteases (30, 31) we next determined whether these enzymes were responsible for our observations. Isolated peripheral blood neutrophils were stimulated with 10-8 M FMLP or with an optimal dilution of zymosan-activated serum (ZAS) but after 30 min, various amounts of proteases or buffer alone were added and incubation was continued to complete 60 min. The cells were then washed using our standard solution, which contains the protease inhibitor PMSF, and prepared for flow cytometry. As shown in Fig. 7, a variety of protease preparations were tested, including trypsin, purified pseudomonas elastase, and purified neutrophil elastase. All of these preparations gave similar results: dose-dependent reduction in CR1 expression with little or no effect on CR3 expression. At the higher inputs of the purified enzymes, CR1 expression was reduced to below the level on the unstimulated control cells. These results thus suggest that our observations on the bronchoalveolar lavage cells could be due to the attack of proteases on the cells, with resultant cleavage of CR1 but not CR3.
In vitro effects of lavagefluid supernatants. Incubation of isolated peripheral blood PMN from a normal donor in the bronchoalveolar lavage supernatant of a pseudomonas-infected CF patient increased CR1 expression to a level twice as high as on cells held at 37°C in buffer alone, but increased CR3 expression on the same cells threefold, as shown at the left of Fig. 8 . This relatively lower degree of upregulation of CR1 was analogous to what had been observed on fresh lavage neutrophils from CF patients. Since the results in the previous section suggested that this might be due to proteases, we determined the effect of preincubating the lavage fluid with the serine-protease inhibitor PMSF. When the neutrophils were incubated with the lavage fluid containing this compound, both receptors were upregulated to the same level. Comparable results were obtained when 10-8 M FMLP was also included, but the maximal level of receptor upregulation was about sixfold higher than on cells in buffer alone. Lavage fluid reduced the CR1 expression to only fourfold without affecting the increase in CR3 expression. Pretreatment ofthe lavage fluid with PMSF eliminated this selective effect on CR1 expression. Incubation of isolated neutrophils with supernatants of lavage fluid from normal donors, both smokers and nonsmokers (n = 4), did not cause upregulation of CR1 or CR3 and did not reduce the amount of CR1 expressed when FMLP was also present (not shown in figure) .
To further define the specificity of the effects of protease inhibitors and thereby identify the enzyme(s) in BAL supernatant responsible for cleaving CR1, we determined whether other inhibitors could also block the reduction of CR1 on FMLP-treated PMN caused by BAL supernatants from CF patients. As shown in Table IV , only a 1-antitrypsin and PMSF inhibited the cleavage of CR1. Bovine serum albumin, included as a control for nonspecific effects of protein; the chelators EDTA and phenanthrolene; and phosphoramidon, which specifically inhibits P. aeruginosa elastase, were all without effect. These results strongly suggest that a serine protease, most likely neutrophil elastase, is responsible for the cleavage of CR 1 we observed. teases were added in a small volume of HBSS/gel and incubation was continued for an additional 30 min. Cells were then washed, aliquoted and prepared for flow cytometry. Results shown are the mean and standard error for three to five experiments. *CR I is less than CR1 on the corresponding FMLP alone or ZAS alone sample with P < 0.05. There were no significant differences in CR3 expression.
Effect of elastase treatment on PMN bactericidal activity.
Since our results suggested that lavage and other inflammatory neutrophils had undergone cleavage of CR1 due to the exposure to neutrophil elastase in vivo, we attempted to determine what effects this might have on the bactericidal activity of the normal neutrophils. As can be seen in Fig. 9, untreated 
Discussion
Neutrophils in the circulation bear relatively few complement receptors or adhesion molecules. Activation of these cells is accompanied by a rapid increase in the surface expression of these proteins, a process that is believed to be necessary for adherence to the endothelium, migration of the cells into tissues, and efficient phagocytosis of complement-coated particles. Indeed, deficiency of CR3, the protein that serves as the iC3b receptor as well as the major PMN adherence molecule, is associated with severe local infections that may occur in the face of extremely elevated numbers of circulating PMNs (6) . This is consistent with the inability of the deficient PMNs to marginate and follow chemotactic gradients into the tissues. Previous studies have shown that PMNs exposed in the circulation to high levels of complement-derived neutrophil activating peptides such as C5a and C5a des-Arg did have increased expression of CR1 and CR3 (7) (8) (9) . In addition, upregulation of CR3 on neutrophils migrating into experimental skin chambers has also been documented (10, 1 1). However, data on the extent of upregulation of these receptors on cells that had migrated into naturally occuring inflammatory sites are not available. In the present study, we examined the response of PMNs in a physiologic model of localized inflammation, the pseudomonas-infected lung in cystic fibrosis. The patients studied had no clinical evidence of disseminated infection or systemic complement activation. Their peripheral blood PMN did not show significantly increased levels of expression of either CR1 or CR3, suggesting that contact of chemoattractants with the cells and subsequent increased adherence of the cells occurred primarily locally, presumably in the pulmonary capillaries. This is apparently an efficient process, as activated cells did not continue to circulate. By examining neutrophil-rich inflammatory fluids, we were able to take advantage of the ability of the flow cytometer to discriminate these cells by their volume and light scattering characteristics and to selectively analyze this cell type without purification or extensive in vitro handling that might have altered their receptor expression. We have previously shown that both resting and activated PMN retain their levels of CR expression when held in vitro at 00 (3) Our results clearly show that the CR1 expression on the lavage neutrophils is much lower than would be expected based on the amount of CR3 expressed. In fact, the degree of expression of the latter receptor in vivo is remarkably similar to that induced under optimal conditions of stimulation in vitro (10-8 M FMLP), suggesting that the cells in these inflammatory exudates are in a similar state of activation. The decreased expression of CR1 does not appear to be related to the degree or type of stimulus per se that the cells encountered in vivo since a wide variety of physiologic stimuli all increase the expression of both receptors in a relatively constant proportion, as shown in Fig. 5 . Furthermore, although the inflammatory cells did respond to FMLP in vitro, the CR1 expression still remained disproportionately low, suggesting that incomplete stimulation of expression was not responsible and that the total cellular pool of CR1 might be depleted. Although they may have a variety of other effects on the inflammatory process, neither corticosteroids nor the NSAID piroxicam appeared to have major effects on receptor expression on the cells that did migrate into the inflammatory site, since the results with patients taking these drugs did not differ from the results with patients not taking any antiinflammatory agent.
Our observations do not appear to be related to the underlying defect in cystic fibrosis, as the peripheral blood cells of these and a previously studied group of CF patients (26) upregulated receptor expression normally in vitro. In addition, results with lavage cells from a child with non-CF chronic P. aeruginosa pulmonary infection and results with cells obtained by arthrocentesis from patients with sterile inflammatory arthritides also showed a similar disproportion in CR1 vs. CR3 expression. It is not likely that immune complexes in the inflammatory fluid caused selective blocking or loss of CR1 alone, since such complexes would also be likely to contain iC3b, which would interact with CR3, and IgG which would interact with Fc receptors. Mixing purified neutrophils with aliquots of lavage fluid that had been stored at -80°did not result in blocking of these receptors and any immune complexes that might have been carried by the lavage cells would most probably have been removed from the cells by the in vitro washes, since CR1 and CR3 are relatively low affinity receptors (32) (33) (34) . Contaminating macrophages are not a likely cause of the observed differences between CR1 and CR3 expression because the analysis gates set on the flow cytometer effectively excluded macrophages, as evidenced by the lack of HLA-DR positive cells (Fig. 1) . Furthermore, results from several other laboratories (35) (36) (37) as well as our own unpublished observations indicate that human alveolar macrophages express very little CR3. Although we have recently shown that some internal degradation of CR1 accompanies neutrophil activation, that phenomenon does not appear to decrease surface expression and is not associated with release of supernatant factors that can remove CR1 from fresh neutrophils (38) . Because the pattern of CR1 and CR3 expression observed on inflammatory neutrophils can be readily reproduced by treating peripheral blood cells with lavage supernatants, we conclude these findings represent a different phenomenon, probably caused by proteases in the lavage fluid.
Since we had previously shown that phenothiazines inhibit CR1 and CR3 expression (29), we considered it possible that the chemically similar phenazine pigments produced by pseudomonas might contribute to the decreased CR1 expression we observed. Evidence against a role for these low molecular weight pseudomonas products in limiting CR1 expression was obtained by testing pyocyanine and phenazine in vitro. Although these pigments are capable of inhibiting lymphocyte activation and block expression of the IL-2 receptor (27, 28), they did not block complement receptor expression during neutrophil activation.
Our in vitro experiments suggest that proteases could be the major factors responsible for the decreased CR1 expression, since these enzymes are clearly capable of cleaving this receptor in vitro. It has recently been proposed that proteolysis is responsible for decreasing CR1 expression during ageing of erythrocytes (39) . Although it is recognized that C3b dependent rosetting is sensitive to trypsin and other serine proteases (30, 31) , it has not been previously shown that CR3 is resistant to such enzymes. Since the monoclonal antireceptor antibodies that we used are specific for the ligand binding sites of the respective receptors, our results probably reflect the ligand binding capacities of the cells as they were in situ. Previous studies have demonstrated both active and complexed proteases in lavage supematants from CF patients (40) (41) (42) (43) (44) (45) , and it has been proposed that neutrophil elastase in the lung fluid is responsible for fragmentation of IgG in situ (43, 45) . Although our results with purified enzymes indicate that both neutrophil and pseudomonas elastases are capable of cleaving CR1, the results of experiments with lavage fluid supernatants show that their anti-CR 1 effect is eliminated by treatment with PMSF, and a1-antitrypsin but not by the metalloprotease inhibitors EDTA or phenanthrolene, nor by phorsphoramidon, a highaffinity inhibitor of pseudomonas elastase (46) . This suggests that PMN elastase, which is a serine-dependent enzyme (47) , rather than pseudomonas or macrophage elastase, which are metalloproteases (46, 48, 49) is responsible for the cleavage of CR1. This result is also consistent with previous studies showing that PMN elastase is the major protease remaining active in CF lavage supernatants (40) (41) (42) (43) (44) (45) . Together with the fact that cells from sterile, PMN-rich inflammatory sites also appear to have undergone similar cleavage, these results strongly support the conclusion that PMN elastase may be the major enzyme responsible for our observations.
The pathogenesis of chronic pulmonary infection in cystic fibrosis remains obscure. Although our results are probably unrelated to the primary genetic defect, we consider it likely that proteolytic degradation of C3b receptors may contribute to inability of CF patients to eradicate infectious agents, especially pseudomonas, from their lungs. This conclusion is strongly supported by our observation that elastase treatment of isolated PMN severely impaired their ability to kill opsonized P. aeruginosa (Fig. 9) . This is not likely to be due to effects on other receptors, since this treatment does not effect CR3, and we have previously shown that it does not affect Fc receptor mediated phagocytosis or neutrophil activation (50) . Several cell types including monocytes, macrophages, B lymphocytes, and some T lymphocytes all carry the same C3b receptor (51) . It thus seems likely that proteolytic attack may cleave this molecule from those cells as well, possibly decreasing the phagocytic activity of monocytes and macrophages and interfering with proper immunologic homeostasis of the affected lymphocytes. Fick et al. have presented evidence that neutrophil elastase in the lung may cleave antipseudomonas IgG, rendering it opsonically ineffective (43) . This may in part explain other observations that antipseudomonas antibodies in CF have antiopsonic activity (52) (53) (54) . It has also been shown that PMN elastase may cleave antigen bound IgG and interfere with the activation of phagocytic cells by immune complexes (45) . Since C3 fragments and IgG normally have synergistic effects in promoting phagocytosis (55, 56), the impaired activity of IgG in CF would place even more emphasis on the necessity for optimal interactions between the complementderived opsonic ligands, C3b and iC3b, and their respective receptors. Our results suggest that these interactions may be deficient in the milieu ofthe pseudomonas-infected lung in CF and that both pseudomonas and host proteases may contribute to initiating a vicious cycle in which neutrophils coming into the infected site actually impair phagocytosis rather than eradicating the source of the infection. Thus, the decreased CR1 expression we have documented in this study, although not directly related to the basic defect in CF, may contribute to a local host defense defect which prevents these patients from eradicating pseudomonas from their lungs. This host defense defect and the vicious cycle of infection and inflammation it promotes eventually become the major causes of morbidity and mortality in this genetic disease.
